68Ga-PSMA PET/CT 显示肝细胞癌表达前列腺特异性膜抗原
FDG 阳性 15 例、PSMA 阳性 16 例,肝病灶平均 SUVmax 分别为 8.3±2.3 与 17.4±9,差异无统计学意义(P>0.1)。结论为 PSMA 表达可被 68Ga-PSMA PET 显示,但不优于 FDG PET,或有助于识别治疗选择有限的患者。
要点
- 晚期肝细胞癌可检出 PSMA 表达,但 68Ga-PSMA PET 总体不优于 FDG PET。
- 肝病灶平均 SUVmax:FDG 8.3±2.3,PSMA 17.4±9,差异无统计学意义(P>0.1)。
- PSMA SUVmax(P=0.05)与 FDG SUVmax(P=0.012)均与总生存呈中等强度相关。
核心结论
- 晚期肝细胞癌的 PSMA 表达可通过 68Ga-PSMA PET 显示,但该检查不优于 FDG PET。
- 68Ga-PSMA PET 或可用于识别治疗选择有限的患者。
研究设计与样本
- 对 18F-FDG PET 与 68Ga-PSMA PET 的 findings 进行视觉与定量(SUVmax)比较。
主要发现
- FDG 阳性 15 例,PSMA 表达阳性 16 例。
- 肝外仅见 1 枚转移淋巴结,两种示踪剂均检出。
- 肝病灶 FDG PET/CT 平均 SUVmax 为 8.3±2.3,平均肿瘤/本底比为 2.3±1.5。
- 68Ga-PSMA PET/CT 相应平均 SUVmax 为 17.4±9,平均肿瘤/本底比为 3.3±2.2。
- 视觉与定量评估中,PSMA 摄取更高 9 例、FDG 更高 4 例、两者相近 3 例;FDG 阳性而 PSMA 阴性 1 例,PSMA 阳性而 FDG 阴性 2 例;3 例呈不均匀摄取。
关键数值与推荐
- 两种 PET 检查的平均 SUVmax 与肿瘤/本底比比较均无统计学显著差异(P>0.1)。
- 平均生存期为 25 个月(范围 18–32 个月)。
- PSMA SUVmax(P=0.05)与 FDG SUVmax(P=0.012)均与总生存呈中等强度相关。
临床怎么用
- 在晚期肝细胞癌再分期中,68Ga-PSMA PET 可显示 PSMA 表达,但不应视为优于 FDG PET 的常规替代。
- 对治疗选择有限的患者,可考虑 68Ga-PSMA PET 以评估 PSMA 表达情况。
局限性
- 肝外转移灶仅见 1 枚淋巴结,对肝外病灶评估受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Prostate specific membrane antigen (PSMA) expression has been demonstrated in tumor neovasculature of many solid tumors, including hepatocellular carcinoma (HCC). The purpose of this study is to evaluate PSMA expression in patients with HCC. MATERIALS AND METHODS: Nineteen HCC patients who underwent F-fluorodeoxyglucose (F-FDG) positron emission tomography (PET) as part of restaging procedure also underwent Ga-PSMA PET. F-FDG PET and Ga-PSMA findings were compared visually as well as quantitatively using maximized standardized uptake values (SUVmax). RESULTS: FDG was positive in 15 patients while 16 patients demonstrated PSMA expression. The only extrahepatic finding was one metastatic lymph node detected by both tracers. Mean SUVmax of liver lesions on FDG PET/CT was 8.3 ± 2.3 and mean tumor to background ratio was 2.3 ± 1.5. Respective values for Ga-PSMA PET/CT were 17.4 ± 9 and 3.3 ± 2.2. On visual and quantitative evaluation uptake was higher with PSMA in nine patients and higher with FDG in four patients. PSMA and FDG activity were similar in three patients. One of the FDG positive patients was PSMA negative whereas two patients were PSMA positive but FDG negative. Heterogeneous uptake pattern was observed in three patients. Comparison of mean SUVmax and T/B values between PET studies revealed no statistically significant difference (P > 0.1). The mean survival was 25 months (range: 18-32 months) and SUVmax of PSMA (P = 0.05) and FDG (P = 0.012) showed medium strength of correlation with overall survival. CONCLUSION: PSMA expression in advanced HCC can be demonstrated by Ga-PSMA PET but is not superior to FDG PET however it could be useful for identifying patients with limited therapeutic options.
引用
- Kuyumcu S, Has-Simsek D, Iliaz R, et al. Evidence of Prostate-Specific Membrane Antigen Expression in Hepatocellular Carcinoma Using 68Ga-PSMA PET/CT. Clin Nucl Med. 2019. PMID: 31348076. doi:10.1097/RLU.0000000000002701
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。